Original ArticleImpact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure
Section snippets
Methods
This was a prospective, observational cohort study, which screened inpatients of cirrhosis admitted in the Department of Hepatology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India from July 2013 to June 2015. The PGIMER, Chandigarh ethics committee approved the study (INT/IEC/2015/493, dated 11/09/2015). All study participants, or their legal guardian, provided informed written consent prior to study enrollment and the study protocol confirmed to the
Acute Decompensation
The diagnosis of cirrhosis was based on clinical, biochemical, and ultrasonography or liver histological data.8, 13 Acute decompensation of cirrhosis was defined as per the criteria of the CANONIC study as development of upper gastrointestinal bleeding, overt ascites over 2 weeks, new onset hepatic encephalopathy (HE), and/or bacterial infection.2 Acute bacterial infection was diagnosed by presence of spontaneous bacterial peritonitis (SBP) (ascitic fluid polymorphonuclear leukocytes >250
Management of Patients
All patients were clinically evaluated including history, physical examination, and routine biochemical and imaging parameters. Work-up for the cause of cirrhosis and acute insult(s) was done for each case. The diagnosis of acute viral hepatitis was based on a positive serology for hepatitis E virus (IgM anti-HEV) or hepatitis A virus (IgM anti-HAV) by ELISA. HBV flare, autoimmune hepatitis (AIH), and Wilson disease were diagnosed based on American Association for the Study of Liver Diseases
Patients
Out of 480 patients with cirrhosis, 179 were found to have acute decompensation. ACLF was diagnosed in 122 patients on admission (Figure 1). Among 122 patients of ACLF, acute insult was hepatic in 47 (38.5%), extrahepatic in 51 (41.8%), combined hepatic and extrahepatic in 15 (12.3%), and was unknown in 9 (7.4%) patients (Figure 1). Alcohol was the most common etiology of cirrhosis in 79 (64.8%) patients followed by cryptogenic, hepatitis C, hepatitis B, AIH, Wilson disease, and primary biliary
Discussion
This study demonstrated that patients with ACLF have higher mortality than patients with acute decompensation not amounting to ACLF; however, there is no difference in 28- and 90-day mortalities based on whether the acute insult was hepatic or extrahepatic. The best prognostic score for hepatic group is iMELD and for extrahepatic group is CLIF-SOFA. Similar to our previous data,7, 8 in the present study, alcohol was the predominant cause of chronic liver disease, alcoholic hepatitis was the
Conclusion
This study demonstrates that while there are differences in severity of underlying liver disease and occurrence of liver failure after the acute insult, there is no difference in extrahepatic organ failure or mortality between ACLF caused by hepatic or extrahepatic insults.
Authors’ Contribution
RKD conceived the idea for the study, wrote the protocol, performed analyses, interpreted data, and prepared the manuscript. TG wrote the protocol, performed analyses, interpreted data, and prepared the manuscript. SR assisted in data collection and patient care management. SA assisted in data analyses, interpreting data, and in preparing the manuscript. ST, AD, and YKC were involved in patient care management and assisted in the interpretation of the data and in preparing the manuscript.
Conflicts of Interest
The authors have none to declare.
Acknowledgements
Tarana Gupta received the best poster award from Indian Society of Gastroenterology for presentation of her research at the 56th Annual Meeting of the Indian Society of Gastroenterology, Indore, India, in November 2015.
References (23)
- et al.
Acute-on-chronic liver failure: a new clinical entity
Clin Gastroenterol Hepatol
(2015) - et al.
Toward an improved definition of acute-on-chronic liver failure
Gastroenterology
(2014) Defining acute-on-chronic liver failure: will East and West ever meet?
Gastroenterology
(2013)- et al.
Patients with acute on chronic liver failure display “sepsis-like” immune paralysis
J Hepatol
(2005) - et al.
Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure
Dig Liver Dis
(2012) - et al.
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
J Hepatol
(2014) - et al.
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
Hepatol Int
(2009) - et al.
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
Gastroenterology
(2013) - et al.
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience
Hepatology
(2012) - et al.
Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF)
Dig Dis Sci
(2010)
Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome
World J Gastroenterol
Cited by (15)
The role of the CLIF-C OF and the 2016 MELD in prognosis of cirrhosis with and without acute-on-chronic liver failure
2019, Annals of HepatologyCitation Excerpt :First, this study confirms that ACLF is an individual entity characterized by high mortality (> 15%) with values reaching 43.6% and 64.1%, respectively for 28 and 90-day, with significant differences from the group without ACLF. This higher mortality, when compared with the CANONIC study (29.6% and 51.1%), can be justified by our very high rate of acute infection in the ACLF group (74.4%) that is known to be a crucial prognosis factor for poor outcome.17-20 Additionally, this study included a considerable percentage of patients with alcohol consumption even when other CLD causes, like chronic HBV or HCV infection, were present.
Current Diagnosis and Classification of Hepatic Encephalopathy
2018, Journal of Clinical and Experimental HepatologyCitation Excerpt :The main reason behind this proposal is the more severe prognostic value of HE in the context of ACLF,21 even if there is no proof of peculiar pathophysiological mechanisms.22 The finding that the increased brain water content is parallel with the degree of HE23 is in line with the view of increased astrocyte hydration in HE.24 It should be emphasized that the concept of brain hyperhydration (‘edema’) should not be confused with the one of intracranial hypertension.
Palliative support in patients with advanced liver disease: Focus on needs rather than prognosis
2018, FMC Formacion Medica Continuada en Atencion PrimariaLiver Transplantation for Acute on Chronic Liver Failure
2017, Journal of Clinical and Experimental HepatologyCitation Excerpt :Some of the Indian studies evaluating mortality of patients with ACLF are shown in Table 2.8,14–21 These studies show a mortality rate ranging from 41.4% (median of 8 days) to 74.5% at 90 days.18,19 It has also been shown that mortality at 28 days and 90 days remains almost similar in presence of hepatic or non-hepatic acute event.19
Acute-on-Chronic Liver Failure: Etiology of Chronic and Acute Precipitating Factors and Their Effect on Mortality
2019, Journal of Clinical and Experimental HepatologyCitation Excerpt :All causes for AD were searched in a particular patient. Although, in this study, we recruited ACLF patients defined by APASL criteria, we took both hepatic and extrahepatic causes as precipitating factors as studies from western literature, and few Indian studies had taken both causes as precipitating factors.6,11 Data of the following variables were collected at the baseline: age, sex, clinical presentation, complete blood counts, liver function tests, kidney function tests, cause of hepatic decompensation, etiology of underlying chronic liver disease (CLD), and outcomes.
Definition, diagnosis and epidemiology of acute-on-chronic liver failure
2023, Liver International